FDA: Pfizer vaccine benefits outweigh risks for children – report
The United States Food and Drug Administration (FDA) determined that benefits outweigh the risks and endorsed Pfizer-BioNTech’s coronavirus vaccine for children aged 5 to 11, The Washington Post reported.
In its analysis, the agency found that the jab proved highly effective in preventing symptomatic infections and caused no safety issues.
Get involved!
Comments